Elevated plasma levels of NT-proBNP in ambulatory patients with peripheral arterial disease.
N-terminal pro B-type natriuretic peptide (NT-proBNP), a cardiac disease biomarker, has been demonstrated to be a strong independent predictor of cardiovascular events in patients without heart failure. Patients with peripheral arterial disease (PAD) are at high risk of cardiovascular events and dea...
Guardado en:
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Public Library of Science (PLoS)
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/fd0e1b5e729e469d90ecb0222c5f7428 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:fd0e1b5e729e469d90ecb0222c5f7428 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:fd0e1b5e729e469d90ecb0222c5f74282021-12-02T20:06:43ZElevated plasma levels of NT-proBNP in ambulatory patients with peripheral arterial disease.1932-620310.1371/journal.pone.0253792https://doaj.org/article/fd0e1b5e729e469d90ecb0222c5f74282021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0253792https://doaj.org/toc/1932-6203N-terminal pro B-type natriuretic peptide (NT-proBNP), a cardiac disease biomarker, has been demonstrated to be a strong independent predictor of cardiovascular events in patients without heart failure. Patients with peripheral arterial disease (PAD) are at high risk of cardiovascular events and death. In this study, we investigated levels of NT-proBNP in patients with PAD compared to non-PAD controls. A total of 355 patients were recruited from outpatient clinics at a tertiary care hospital network. Plasma NT-proBNP levels were quantified using protein multiplex. There were 279 patients with both clinical and diagnostic features of PAD and 76 control patients without PAD (non-PAD cohort). Compared with non-PAD patients, median (IQR) NT-proBNP levels in PAD patients were significantly higher (225 ng/L (120-363) vs 285 ng/L (188-425), p- value = 0.001, respectively). Regression analysis demonstrated that NT-proBNP remained significantly higher in patients with PAD relative to non-PAD despite adjusting for age, sex, hypercholesterolemia, smoking and hypertension [odds ratio = 1.28 (1.07-1.54), p-value <0.05]. Subgroup analysis showed elevated NT-proBNP levels in patients with PAD regardless of prior history of CHF, CAD, diabetes and hypercholesteremia (p-value <0.05). Finally, spearmen's correlation analysis demonstrated a negative correlation between NT-proBNP and ABI (ρ = -0.242; p-value < 0.001). In conclusion, our data shows that patients with PAD in an ambulatory care setting have elevated levels of NT-proBNP compared to non-PAD patients in the absence of cardiac symptoms.Bader AlsuwailemAbdelrahman ZamzamMuzammil H SyedElisa GrecoMark WheatcroftCharles de MestralMohammed Al-OmranJohn HarlockJohn EikelboomKrishna K SinghRawand AbdinMohammad QaduraPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 7, p e0253792 (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Bader Alsuwailem Abdelrahman Zamzam Muzammil H Syed Elisa Greco Mark Wheatcroft Charles de Mestral Mohammed Al-Omran John Harlock John Eikelboom Krishna K Singh Rawand Abdin Mohammad Qadura Elevated plasma levels of NT-proBNP in ambulatory patients with peripheral arterial disease. |
| description |
N-terminal pro B-type natriuretic peptide (NT-proBNP), a cardiac disease biomarker, has been demonstrated to be a strong independent predictor of cardiovascular events in patients without heart failure. Patients with peripheral arterial disease (PAD) are at high risk of cardiovascular events and death. In this study, we investigated levels of NT-proBNP in patients with PAD compared to non-PAD controls. A total of 355 patients were recruited from outpatient clinics at a tertiary care hospital network. Plasma NT-proBNP levels were quantified using protein multiplex. There were 279 patients with both clinical and diagnostic features of PAD and 76 control patients without PAD (non-PAD cohort). Compared with non-PAD patients, median (IQR) NT-proBNP levels in PAD patients were significantly higher (225 ng/L (120-363) vs 285 ng/L (188-425), p- value = 0.001, respectively). Regression analysis demonstrated that NT-proBNP remained significantly higher in patients with PAD relative to non-PAD despite adjusting for age, sex, hypercholesterolemia, smoking and hypertension [odds ratio = 1.28 (1.07-1.54), p-value <0.05]. Subgroup analysis showed elevated NT-proBNP levels in patients with PAD regardless of prior history of CHF, CAD, diabetes and hypercholesteremia (p-value <0.05). Finally, spearmen's correlation analysis demonstrated a negative correlation between NT-proBNP and ABI (ρ = -0.242; p-value < 0.001). In conclusion, our data shows that patients with PAD in an ambulatory care setting have elevated levels of NT-proBNP compared to non-PAD patients in the absence of cardiac symptoms. |
| format |
article |
| author |
Bader Alsuwailem Abdelrahman Zamzam Muzammil H Syed Elisa Greco Mark Wheatcroft Charles de Mestral Mohammed Al-Omran John Harlock John Eikelboom Krishna K Singh Rawand Abdin Mohammad Qadura |
| author_facet |
Bader Alsuwailem Abdelrahman Zamzam Muzammil H Syed Elisa Greco Mark Wheatcroft Charles de Mestral Mohammed Al-Omran John Harlock John Eikelboom Krishna K Singh Rawand Abdin Mohammad Qadura |
| author_sort |
Bader Alsuwailem |
| title |
Elevated plasma levels of NT-proBNP in ambulatory patients with peripheral arterial disease. |
| title_short |
Elevated plasma levels of NT-proBNP in ambulatory patients with peripheral arterial disease. |
| title_full |
Elevated plasma levels of NT-proBNP in ambulatory patients with peripheral arterial disease. |
| title_fullStr |
Elevated plasma levels of NT-proBNP in ambulatory patients with peripheral arterial disease. |
| title_full_unstemmed |
Elevated plasma levels of NT-proBNP in ambulatory patients with peripheral arterial disease. |
| title_sort |
elevated plasma levels of nt-probnp in ambulatory patients with peripheral arterial disease. |
| publisher |
Public Library of Science (PLoS) |
| publishDate |
2021 |
| url |
https://doaj.org/article/fd0e1b5e729e469d90ecb0222c5f7428 |
| work_keys_str_mv |
AT baderalsuwailem elevatedplasmalevelsofntprobnpinambulatorypatientswithperipheralarterialdisease AT abdelrahmanzamzam elevatedplasmalevelsofntprobnpinambulatorypatientswithperipheralarterialdisease AT muzammilhsyed elevatedplasmalevelsofntprobnpinambulatorypatientswithperipheralarterialdisease AT elisagreco elevatedplasmalevelsofntprobnpinambulatorypatientswithperipheralarterialdisease AT markwheatcroft elevatedplasmalevelsofntprobnpinambulatorypatientswithperipheralarterialdisease AT charlesdemestral elevatedplasmalevelsofntprobnpinambulatorypatientswithperipheralarterialdisease AT mohammedalomran elevatedplasmalevelsofntprobnpinambulatorypatientswithperipheralarterialdisease AT johnharlock elevatedplasmalevelsofntprobnpinambulatorypatientswithperipheralarterialdisease AT johneikelboom elevatedplasmalevelsofntprobnpinambulatorypatientswithperipheralarterialdisease AT krishnaksingh elevatedplasmalevelsofntprobnpinambulatorypatientswithperipheralarterialdisease AT rawandabdin elevatedplasmalevelsofntprobnpinambulatorypatientswithperipheralarterialdisease AT mohammadqadura elevatedplasmalevelsofntprobnpinambulatorypatientswithperipheralarterialdisease |
| _version_ |
1718375400406515712 |